Skip to content

A clinical pathway for older prostate cancer patients

A clinical pathway for older prostate cancer patients - Clinical Pathway Prostate Cancer

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON40972
Enrollment
20
Registered
2014-07-22
Start date
2014-10-04
Completion date
Unknown
Last updated
2024-04-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

malignancy of the prostate Prostate cancer

Interventions

None listed

Sponsors

NIVEL
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: In order to be eligible to participate in this study, a subject must meet all of the following criteria: • Diagnosis of prostate cancer • Age at least 65 and at least one chronic disease (of a list of 30 diseases of the RIVM);Specific criteria for the different treatment options: After radical prostatectomy inclusion 1 year after operation if: • PSA

Exclusion criteria

Exclusion criteria: - In active medical treatment - After-care by GP not medically safe - in the normal situation the patient would be checked by the urologist for at least one year

Design outcomes

Primary

MeasureTime frame
The primary outcome measure of this project is the existence of a succesful clinical pathway for older prostate cancer patients. This will be assessed by the following criteria: - GPs do not refer patients to the urologist (unless for recurrence/metastasis). - The majority of the patients is satisfied - The participating GPs and urologists are convinced and confident

Secondary

MeasureTime frame
perceived quality of care and prostate cancer specific quality of life, health care use and satisfaction with videoconsultations

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)